Michael C Keefer

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. pmc A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults
    Michael C Keefer
    University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America
    PLoS ONE 7:e41936. 2012
  2. pmc Barriers and Facilitators of Online Patient Portals to Personal Health Records Among Persons Living With HIV: Formative Research
    Amneris E Luque
    Department of Medicine, Infectious Disease Division, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States
    JMIR Res Protoc 2:e8. 2013
  3. pmc A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects
    Michael C Keefer
    Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA michael
    Vaccine 29:1948-58. 2011
  4. doi request reprint Bridging the digital divide in HIV care: a pilot study of an iPod personal health record
    Amneris E Luque
    Department of Medicine, Infectious Disease Division, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
    J Int Assoc Provid AIDS Care 12:117-21. 2013
  5. pmc 9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity
    James J Kobie
    Division of Allergy, University of Rochester Medical Center, Rochester, New York, United States of America
    PLoS ONE 7:e35356. 2012

Research Grants

  1. HIV VACCINE CLINICAL TRIALS UNIT
    Michael Keefer; Fiscal Year: 2006

Collaborators

Detail Information

Publications5

  1. pmc A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults
    Michael C Keefer
    University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America
    PLoS ONE 7:e41936. 2012
    ..The trial enrolled 56 healthy HIV-uninfected adults...
  2. pmc Barriers and Facilitators of Online Patient Portals to Personal Health Records Among Persons Living With HIV: Formative Research
    Amneris E Luque
    Department of Medicine, Infectious Disease Division, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States
    JMIR Res Protoc 2:e8. 2013
    ..However, relatively little is known regarding barriers and facilitators for vulnerable groups such as persons living with human immunodeficiency virus (PLWH)...
  3. pmc A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects
    Michael C Keefer
    Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA michael
    Vaccine 29:1948-58. 2011
    ..Thus, a heterologous poxvirus vector prime-boost regimen can induce HIV-specific CD8+ T-cell and CD4+ T-cell responses, which may be an important feature of an optimal regimen for preventive HIV vaccination...
  4. doi request reprint Bridging the digital divide in HIV care: a pilot study of an iPod personal health record
    Amneris E Luque
    Department of Medicine, Infectious Disease Division, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
    J Int Assoc Provid AIDS Care 12:117-21. 2013
    ..Persons living with HIV (PLWH) need practical tools to self-manage their condition...
  5. pmc 9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity
    James J Kobie
    Division of Allergy, University of Rochester Medical Center, Rochester, New York, United States of America
    PLoS ONE 7:e35356. 2012
    ..Our results suggest that the development of HIV BNAbs is not merely a consequence of a general breakdown in tolerance, but rather a more intricate expansion of selective autoreactive B cells and antibodies...

Research Grants1

  1. HIV VACCINE CLINICAL TRIALS UNIT
    Michael Keefer; Fiscal Year: 2006
    ..abstract_text> ..